Table 4.
Greater Areas of Activity in OPRM1.G Group Compared With the Control Group
| Region | BA | Peak Z-score | TLRC |
|---|---|---|---|
| OPRM1.G > Controls | |||
| Prepriming | |||
| L ACG | 25 | 2.44 | −1, 23, −9 |
| L OFC* | 11 | 2.41 | −26, 35, −13 |
| L VS/NAc | – | 2.27 | −30, 9, −11 |
| L OFC* | 11 | 2.25 | −40, 37, −13 |
| R IFG | 47 | 2.24 | 30, 21, −13 |
| R VS/NAc | – | 2.17 | 28, 7, −13 |
| R IFG | 47 | 2.15 | 28, 19, −13 |
| R ACG | 32 | 1.99 | 10, 29, −11 |
| Postpriming | |||
| L IFG | 47 | 2.36 | −28, 33, −7 |
| L globus pallidus | – | 2.13 | −18, 1, −5 |
| L ACG | 24 | 2.10 | −12, 27, −3 |
| R OFC | 11 | 2.08 | 15, 55, −17 |
| L ACG | 25 | 2.04 | −2, 11, −5 |
| L OFC | 11 | 2.01 | −16, 53, −17 |
| R claustrum | – | 1.88 | 30, 11, −7 |
| R putamen | – | 1.87 | 18, 15, −7 |
| R putamen | – | 1.82 | 20, 17, −7 |
| R IFG | 47 | 1.81 | 34, 23, −9 |
| R medial frontal gyrus | 11 | 1.72 | 4, 47, −11 |
| Controls > OPRM1.G | |||
| Prepriming | |||
| R middle frontal gyrus | 10 | 3.83 | 30, 51, −1 |
| R ACG | 32 | 3.03 | 16, 39, 1 |
| R globus pallidus | – | 2.47 | 18, −5, 5 |
| R caudate | – | 2.46 | 22, 19, 7 |
| L thalamus | – | 2.04 | −18, −9, 9 |
| R IFG | 47 | 1.94 | 16, 15, −23 |
| L middle frontal gyrus | 10 | 1.86 | −22, 51, −1 |
| R IFG | 11 | 1.80 | 26, 31, −25 |
| L VTA/midbrain | – | 1.65 | −15, −16, −13 |
| Postpriming | |||
| R IFG | 47 | 3.00 | 18, 13, −23 |
| L IFG | 47 | 2.22 | −16, 15, −23 |
| L IFG | 11 | 2.13 | −24, 29, −25 |
| R medial frontal gyrus | 9 | 1.89 | 6, 51, 23 |
| L medial frontal gyrus | 10 | 1.83 | −18, 49, −3 |
| L medial frontal gyrus | 10 | 1.70 | −12, 47, 1 |
| L medial frontal gyrus | 10 | 1.70 | −6, 55, 15 |
| R IFG | 47 | 1.67 | 26, 25, −23 |
L, left; R, right; ACG, anterior cingulate gyrus; OFC, orbitofrontal cortex; VS/NAc, ventral striatum/nucleus accumbens; IFG, inferior frontal gyrus; VTA, ventral tegmental area.
The OPRM1.G subjects had greater BOLD response in all of the ROIs (except the VTA) before and after priming compared with the controls. Maximum loci of activation are listed for each substrate as anatomical labels, corresponding Brodmann area (BA), peak z-score and Talairach (TLRC) co-ordinates of greater BOLD response in the risk allele group compared with the nonrisk allele group (p < 0.05).
Foci of activation (i.e., L OFC) that overlap with DRD4.L individuals.